The oncogenicity of human cytomegalovirus.
D000230:Adenocarcinoma / Q000382:microbiology; D000956:Antigens, Viral / Q000276:immunology; D002472:Cell Transformation, Viral; D002478:Cells, Cultured; D003110:Colonic Neoplasms / Q000382:microbiology; D003587:Cytomegalovirus / Q000276:immunology / Q000472:pathogenicity*; D003586:Cytomegalovirus Infections / Q000150:complications*; D004264:DNA Topoisomerases, Type I / Q000378:metabolism; D004279:DNA, Viral / Q000032:analysis*; D004259:DNA-Directed DNA Polymerase / Q000378:metabolism; D004789:Enzyme Activation; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D009369:Neoplasms / Q000382:microbiology*; D009955:Ornithine Decarboxylase / Q000378:metabolism; D011470:Prostatic Hyperplasia / Q000382:microbiology; D011471:Prostatic Neoplasms / Q000382:microbiology; D012514:Sarcoma, Kaposi / Q000382:microbiology; D013937:Thymidine Kinase / Q000378:metabolism; D002583:Uterine Cervical Neoplasms / Q000382:microbiology
D000956:Antigens, Viral; D004279:DNA, Viral; D013937:Thymidine Kinase; D004259:DNA-Directed DNA Polymerase; D009955:Ornithine Decarboxylase; D004264:DNA Topoisomerases, Type I